Evidence map›Paper›PMID 33658987›Full record

ArticleFrontiers in microbiology2021

Silver Nanoparticles Induce a

Vikram Pareek, Stéphanie Devineau, Sathesh K Sivasankaran, Arpit Bhargava, Jitendra Panwar, Shabarinath Srikumar, Séamus Fanning

Open access · goldAbstract read
In one paragraph

Article in Frontiers in microbiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 43 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Green Synthesis of Silver Nanoparticles UsingMaterials (Basel, Switzerland) · 2022
    Article
  11. Green Synthesis of Silver Nanoparticles UsingNanomaterials (Basel, Switzerland) · 2022
    Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 6 countries.

Vikram PareekUCD-Centre for Food Safety, UCD School of Public Health, Physiotherapy and Sports Science, University College Dublin, Dublin, Ireland.
Stéphanie DevineauUniversité de Paris, BFA, UMR 8251, CNRS, Paris, France.
Sathesh K SivasankaranGenome Informatics Facility, Iowa State University, Ames, IA, United States.
Arpit BhargavaDepartment of Biological Sciences, Birla Institute of Technology and Science, Pilani, India.
Jitendra PanwarDepartment of Biological Sciences, Birla Institute of Technology and Science, Pilani, India.
Shabarinath SrikumarDepartment of Food, Nutrition and Health, College of Food and Agriculture, UAE University, Al Ain, United Arab Emirates.
Séamus FanningUCD-Centre for Food Safety, UCD School of Public Health, Physiotherapy and Sports Science, University College Dublin, Dublin, Ireland.
Birla Institute of Technology and Science, Pilani · INCentre National de la Recherche Scientifique · FRIowa State University · USQueen's University Belfast · GBUnited Arab Emirates University · AE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Infections associated with antimicrobial-resistant bacteria now represent a significant threat to human health using conventional therapy, necessitating the development of alternate and more effective antibacterial compounds. Silver nanoparticles (Ag NPs) have been proposed as potential antimicrobial agents to combat infections. A complete understanding of their antimicrobial activity is required before these molecules can be used in therapy. Lysozyme coated Ag NPs were synthesized and characterized by TEM-EDS, XRD, UV-vis, FTIR spectroscopy, zeta potential, and oxidative potential assay. Biochemical assays and deep level transcriptional analysis using RNA sequencing were used to decipher how Ag NPs exert their antibacterial action against multi-drug resistant

Indexed as

Klebsiella pneumoniaeRNA sequencingsilver nanoparticlessoxStriclosan

Identifiers

PMID33658987
PMCPMC7917072
OpenAlexW3129270315

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.